md-medicaldata

Authors

 

Almedina Hajrović¹, Snežana Unčanin^1,2, Sanela Hajro^1,2, Selvedina Duškan<sup>1,2

1</sup>Fakultet zdravstvenih studija, Univerzitet u Sarajevu
²Univerzitetski Klinički Centar u Sarajevu

 

UDK: 618.177-074 : 577.175.6

The paper was received / Rad primljen: 12.09.2021.

Accepted / Rad prihvaćen: 30.09.2021.

 

Correspondence to:

Mr. Almedina Hajrović, ass.
Fakultet zdravstvenih studija
Univerzitet u Sarajevu
e-mail: almedina.ha@hotmail.com

 

 

Sažetak

 

Obzirom da su vrlo česti problemi današnjice neplodnost različite etiologije, kao i  pronalazak adekvatnog terapijskog postupka, neizostavno i vrlo važnu ulogu ima laboratorijsko određivanje korisnih hormonskih markera ovarijske rezerve. Od najznačajnijih hormonskih screening testova  neizostavan je Anti-Müllerov hormon (AMH), a potom folikostimulirajući hormon (FSH), estradiol koji su precizniji testovi u odnosu na inhibin B i klomifen citratni test  (CC) test. Anti-Müllerov hormon (AMH) je najznačajniji laboratorijski prediktor ovarijske rezerve. Samostalno određivanje koncentracije estradiola i koncentracije FSH ne bi trebalo se upotrebljavati u procjeni ovarijske rezerve, prvenstveno zbog varijacije hormona tokom menstrualnog ciklusa. Vrijednosti estradiola jedino mogu poslužiti kao unutarnja kontrola faze menstrualnog ciklusa, dok FSH za procjenu folikulogeneze, perimenopauzalnog statusa, hipergonadotropnog i hipogonadotropnog gonadizma, te centralnog preuranjenog puberteta. Međutim, AMH u kombinaciji sa hormonima kao što su FSH i estradiol ljekar uz druge dijagnostičke (ultrazvučne) procedure dobiva sagledivu sliku u smislu terapijskog tretmana, što i ukazuje na sam značaj laboratorijskog određivanja navedenih hormona u procjeni ovarijske rezerve. Kada je u pitanju osjetljivost i specifičnost metoda određivanja navedenih hormona, iste su vremenom razvijane, te su imunohemijske metode u širokoj primjeni s zadovoljavajućom osjetljivošću i specifičnošću.

 

Ključne riječi

ovarijska rezerva, Anti-Müllerov hormon (AMH), FSH, estradiol, imunohemijske metode

 

 

 

Abstract

 

Given that very common problems today are infertility of various etiologies, as well as finding an adequate therapeutic procedure, inevitably and very important role is played by laboratory determination of useful hormonal markers of ovarian reserve. Of the most important hormone screening tests, the Anti-Müller hormone (AMH) is indispensable, followed by folcostimulating hormone (FSH), estradiol, which are more precise tests compared to inhibin B and the clomiphene citrate test (CC) test. Self-determination of estradiol concentration and FSH concentration should not be used in the assessment of ovarian reserve, primarily due to hormone variation during the menstrual cycle. Estradiol values ​​can only serve as an internal control of the menstrual cycle phase, while FSH to assess folliculogenesis, perimenopausal status, hypergonadotropic and hypogonadotropic gonadism, and central premature puberty. However, AMH in combination with hormones such as FSH and estradiol, along with other diagnostic (ultrasound) procedures, the doctor gets a clear picture in terms of therapeutic treatment, which indicates the importance of laboratory determination of these hormones in the assessment of ovarian reserve. When it comes to the sensitivity and specificity of the methods for determining these hormones, they have evolved over time, and immunochemical methods are widely used with satisfactory sensitivity and specificity.

Key words:

ovarian reserve, Anti-Müller hormone (AMH), FSH, estradiol, immunochemical methods

 

 

 

 

References:

1. Piskač T. Uzroci bračne neplodnosti. Diss. University of Zagreb. School of Medicine. Department of Gynecology and Obstetrics, 2020.
2. Vander Borght M, Wyns C. Fertility and infertility: Definition and epidemiology. Clin Biochem.
   2018 Dec;62:2-10.
3. Jelinek D. Induction of ovulation in women with reduced ovarian reserve . Diss. University of Zagreb. School of Medicine. Chair of Gynecology and Obstetrics, 2018.
4. Mahovlić L. Biljezi ovarijske rezerve. Diss. University of Zagreb. School of Medicine. Chair of Gynecology and Obstetrics, 2017.
5. Palčić Z. Analiza ovarijske rezerve pacijentica liječenih postupcima medicinski potpomognute oplodnje na Zavodu za ginekološku endokirnologiju I humanu reprodukciju, Klinike za ženske bolesti I porode KKBC-a Split. Diss. University of Split. School of Medicine. Gynecology and obstetrics, 2017.
6. Perić M. Obrada neplodnog para. Diss. University of Zagreb. School of Medicine. Department of Gynecology and Obstetrics, 2019.
7. Tal R, Seifer DB. Ovarian reserve testing: a user’s guide. Am J Obstet Gynecol. 2017;217(2):129-140
8. Nelson SM, Klein BM, Arce JC. Comparison of antimullerian hormone levels and antral follicle count as predictor of ovarian response to controlled ovarian stimulation in good-prognosis patients at individual fertility clinics in two multicenter trials. Fertil Steril. 2015;103(4):923-930.
9. Tal R, Tal O, Seifer BJ, Seifer DB. Antimüllerian hormone as predictor of implantation and clinical pregnancy after assisted conception: a systematic review and meta-analysis. Fertil Steril. 2015;103(1):119-130.
10. Strauss III JF, Barbieri RL, Yen & Jaffe's Reproductive Endocrinology, Physiology, Pathophysiology, and Clinical Management. 8. izd. Philadelphia: Elsevier; 2019.
11. Bhide P, Homburg R. Anti-Müllerian hormone and polycystic ovary syndrome. Best Pract Res Clin Obstet Gynaecol. 2016;37:38-45.
12. La Marca A, Broekmans FJ, Volpe A, Fauser BC, Macklon NS. Anti-Müllerian hormone (AMH): what do we still need to know? Hum Reprod. 2009;24(9):2264-2275
13. La Marca A, Volpe A. Anti‐Müllerian hormone (AMH) in female reproduction: is measurement of circulating AMH a useful tool? Clin Endocrinol. 2006;64:603-610.
14. Dumanić K. Utjecaj oralne hormonske kontracepcije na reprodukcijsku rezervu jajnika. Diss. University of Split. School of Medicine. Pharmacology, 2018.
15. Škrgatić L. Važnije laboratorijske vrijednosti i pretvorba nalaza.U: Šimunić V. i sur. Reprodukcijska endokrinologija i neplodnost. Zagreb: Školska knjiga; 2012. str. 697-699
16. Broer S, Broekmans F, Laven J, Fauser B. Anti-Müllerian hormone: ovarian reserve testing and its potential clinical implications. Hum Reprod. 2014;20(5):688-701.
17. Streuli I, Fraisse T, Pillet C, Ibecheole V, Bischof P, de Ziegler D. Serum antimüllerian hormone levels remain stable throughout the menstrual cycle and after oral or vaginal administration of synthetic sex steroids. Fertility and Sterility. 2008;90(2):395-400.
18. Brkić I. Povezanost dobi i koncentracije AMH. Diss. University of Zagreb. Faculty of Pharmacy and Biochemistry. Department of medical biochemistry and haematology, 2017.
19. Wise PM, Suzuki S, Brown CM. Estradiol: a hormone with diverse and contradictory neuroprotective actions. Dialogues Clin Neurosci. 2009;11(3):297-303.
20. Parry, J. P. and Koch, C. A. (2016) ‘Ovarian Reserve Testing’. Available at: http://www.endotext.org/chapter/ovarian-reserve-testing1/.
21. Practice Committee of the American Society for Reproductive Medicine. Diagnostic evaluation of the infertile female: a committee opinion. Fertil Steril. 2012;98:302–7.
22. Roudebush, W. E., Kivens, W. J. and Mattke, J. M. (2008) ‘Biomarkers of ovarian reserve’, Biomarker Insights, 2008(3), p. 1–23.
23. Hanulak J. Hormonski disbalans kao uzrok neplodnosti muškaraca. Diss. Josip Juraj Strossmayer University of Osijek. Faculty of Medicine., 2018.
24. Goldštajn Šprem M. Umanjena funkcija jajnika i prijevremena menopauza. U:  Šimunić V i sur. Reprodukcijska endokrinologija i neplodnost; Medicinski potpomognuta oplodnja, IVF. Zagreb: Školska knjiga; 2012. str. 297-307.
    

PDF: 06-MD-Vol 13 No 3-4 Sept-Dec 2021_Hajrović A. et al..pdf